Efecto disruptor del ciclo estral de un extracto etanólico de hojas de Buddleja globosa y de su componente principal (verbascósido) by Lara, Hernán et al.
  
© 2014  
Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas 13 (2): 189 - 197 
ISSN 0717 7917 
www.blacpma.usach.cl 
 
 
Artículo Original | Original Article 
189 
 
 
Estrous cycle disruptor effect of an ethanolic extract from 
Buddleja globosa leaves and its main component (verbascoside) 
 [Efecto disruptor del ciclo estral de un extracto etanólico de hojas de Buddleja globosa  
y de su componente principal (verbascósido)] 
 
 
Mirtha PARADA
1,2,3
, Gabriela VALENZUELA-BARRA
2
, Carla DELPORTE
2
 & Hernán LARA
1
 
 
1Laboratorio de Neurobioquímica, 2Laboratorio de Productos Naturales, Facultad de Ciencias Químicas y Farmacéuticas,  
Universidad de Chile, 3Instituto de Salud Pública. Chile 
Contactos | Contacts: Hernán LARA- E-mail address: hlara@ciq.uchile.cl 
 
 
 
Abstract: The estrous cycle disruptor effect of an ethanolic extract (EMATst) from Buddleja globosa leaves and standardized in its main 
component (verbascoside) was determined in rats after the subcutaneous administration of EMATst. Binding of EMATst and verbascoside 
to the estrogen receptor (ER) of EMATst and verbacoside was also measuredestablished. EMATst produced a significant alteration inof the 
estrous cycle only at the highest dose (10-5 M), which could be attributed to an antiestrogenic effect. The Bbinding of EMATst and 
verbascoside to the ER was competitive and occurred in concentrations 1000 times greater than that of 17β-estradiol. 
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Resumen: El efecto disruptor del ciclo estral de un extracto etanólico (EMATst) obtenido a partir de las hojas de Buddleja globosa y 
estandarizado en su componente mayoritario (verbascósido) fue determinado en ratas después de la administración subcutánea de EMATst. 
Se estableció además la unión al receptor estrogénico (RE) tanto de EMATst como de verbascósido. EMATst sólo a la dosis más alta (10-
5M) produjo una alteración significativa del ciclo estral, lo que podría atribuirse a un efecto antiestrogénico. La unión al RE de EMATst y 
verbascósido se produjo a concentraciones 1000 veces mayor que el 17β-estradiol y de forma competitiva. 
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INTRODUCTION 
Endocrine disruptors (ED) are a group of natural or 
synthetic chemical substances exogenous to the 
human organism; these compounds interfere with the 
mechanism of the hormones responsible for the 
maintenance of homeostasis and the regulation of 
development and have various origins, structures and 
uses (Olea et al., 2002). Compounds with estrogenic 
or antiestrogenic activity present in plants are called 
phytoestrogens, from which isoflavones, lignans, 
coumestans, flavonoids and stilbenes have been 
identified (Papoutsi et al., 2006). Studies on 
isoflavones have reported that isoflavones exhibit 
estrogenic and antiestrogenic properties, compete for 
the estrogen receptor and exhibit biphasic activity: 
estrogenic action at low concentrations (< 10
-6
 M) and 
anti-estrogenic activity at high concentrations (>10
-6
 
M) (Papoutsi et al., 2006). 
Phytoestrogens may or may not be beneficial, 
depending on the age at exposure and/or whether the 
compounds act at the intrauterine or postnatal stages 
of development, especially for those substances that 
cross the placental barrier or are passed through breast 
milk (Olea et al., 2002). 
Previous studies have reported that farm 
and wild animals that have consumed large 
quantities of plants rich in phytoestrogens exhibit 
problems with reproduction and fertility (Leopold 
et al., 1976, Berger et al., 1977). These same 
problems were observed in Australian sheep due to 
the consumption of phytoestrogens in a species of 
clover (Trifolium subterraneum); equol and 
coumestrol were identified as being responsible for 
this effect (Bennetts and Underwood, 1951). These 
phytoestrogens have also been suggested to be the 
reason why cheetahs in captivity tend to be infertile, 
due to the consumption of food rich in soy (Setchell 
et al., 1987). With respect to the early stages of 
development, rats and mice exposed before or at birth 
to coumestrol and genistein have been shown to 
develop anomalies in the reproductive apparatus, 
such as changes in ovarian development, sub-fertility, 
infertility and alterations in the estrous cycle (Delclos 
et al., 2001; Jefferson et al., 2002; Jefferson et al., 
2005; Jefferson et al., 2006).  
Buddleja globosa Hope (Buddlejaceae) is a 
native species (common name: matico) cultivated in 
Chile, Peru and Argentina that is used in herbal 
medicine. 
In our laboratory, recent investigations with 
sequential extracts of leaves have isolated a mixture of 
β-sitosterol, stigmasterol, stigmastenol, stigmastanol 
and campesterol from dichloromethane extract, and 
the standardized ethanol extract in verbascoside 
(EMATst) is composed mainly of phenylpropanoids, 
such as verbascoside, and flavonoids, such as the 7-O-
glucoside of luteolin (Backhouse et al., 2008a, 
Backhouse et al., 2008b). Our “in vivo” 
pharmacological studies of these extracts have 
demonstrated their anti-inflammatory activity orally 
and topically, as well as their scarring, anti-oxidant 
and analgesic effects (Backhouse et al., 2008a, 
Backhouse et al., 2008b). 
 The estrogenic effect of verbascoside 
isolated from Verbascun macrucurum was 
measured by Papoutsi et al. (2006), who evaluated 
its estrogenic effect on osteoblasts, its anti-
estrogenic effect on mammalian MCF-7 cancer 
cells and its anti-proliferative effect on the 
endometrium using the Ishikawa cell line. The 
authors also demonstrated its alpha estrogen 
receptor antagonist properties in HeLa cells. 
Activity-structure tests “in vitro” to elucidate the 
relative binding affinity of the estrogen receptor 
demonstrated that the flavones bind to the estrogen 
receptor (Heckmann et al., 2008). The 7-O-glucoside 
of luteolin apparently does not contribute to the 
estrogenic effect of EMATst due to the substitution 
of the hydroxyl group in C-7 by glucose (Fang et al., 
2001).  
 The present investigation was undertaken to 
establish the estrous cycle disruptor effect of 
EMATst and its main component (verbascoside) to 
obtain new insights into reproductive performance 
and to confirm its binding to the estrogen receptor. 
 
MATERIALS AND METHODS 
General experimental procedures 
1
H NMR and 
13
C NMR measurements were 
performed in DMSO and CD 3OD at 400 MHz 
for 
1
H and 100 MHz for 
13
C with TMS as 
internal standard. For HPLC-DAD analysis, the 
retention time, UV spectra and verbascoside content in 
EMAT were measured in a HPLC Waters 486 
equipment with a coupled UV-VIS diode array 
detector using a Hibar Purospher Star RP-18 (250×4 
mm, 5 μm) column (Merck, Germany) at room 
temperature. Verbascoside and caffeic acid standards 
were purchased from Sigma (MO, USA). Thin layer 
chromatography (TLC) was performed on silica gel 
GF254 (Merck 5554). Spots were detected under UV 
light and after spraying with NP/PEG reagent. 
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Plant Material 
The leaves of Budlleja globosa  were collected 
in January, 2008 in the Antumapu Campus of the 
Universidad de Chile, Santiago, Chile; a voucher 
specimen is kept at the herbarium of the Faculty of 
Chemical Sciences and Pharmacy (SQF: 22349), 
Universidad de Chile. The plant was identified by Dr. 
Carla Delporte. 
 
Extraction and verbascoside isolation  
Dry ground leaves of B. globosa were sequentially 
extracted at room temperature with solvents of 
increasing polarity, according to methodology 
described by Backhouse et al. (2008b). 
 Air-dried and powdered leaves (1.94 kg) were 
sequentially extracted at room temperature with n-
hexane (H), CH2Cl2 (DCM) and MeOH, yielding, after 
removing the solvents under reduced pressure, 42.2 g 
of HE (2.1%), 26.3 g of DCME (1.4%) and 163 g of 
(8.4%) EMAT extracts, respectively. 
 EMAT (12.4 g) was subjected to CC on silica 
gel, eluted with solvent mixtures of increasing polarity 
from 100% CH2Cl2 to 100% EtOAc. Fractions eluted 
with DCM:EtOAc (20:80) and EtOAc 100% yielded 
verbascoside (72.4 mg), which in the TLC analysis 
was a light blue spot (NP-PEG reagent); Rf 0.7 
(EtOAc:CH3OH 8:2) was coincident with a standard 
sample of verbascoside. The presence of verbascoside 
was confirmed by a) 1H NMR and 13C NMR 
measurements and b) comparison between the 
retention time and UV spectrum (obtained between 
200 and 400 nm) by HPLC-DAD with a verbascoside 
standard.  
 
Determination of verbascoside content in EMAT by 
HPLC-DAD 
The solvent system used was formic acid 
(0.1%):acetonitrile (70:30) at a flow rate of 0.5 
mL/min and with UV detection at 365 nm. A simple 
filtration was performed on the sample using a 0.22-
μm PTFE filter before HPLC-DAD analysis. The 
injection volume was 20 L with a concentration of 
EMAT of 1.58 mg/mL dissolved in methanol. This 
quantitative analysis was performed in triplicate. 
 A calibration curve was constructed with 
caffeic acid dissolved in methanol (115, 321, 462, 925 
and 1850 ppm) as standard substance under the same 
conditions mentioned as EMAT (y = 15966 x - 
416796, R
2
 = 0.9985 and F calculated 2.07 < F table 
3.71). The verbascoside content was 0.61 mg ± 0.01; 
its equivalent in caffeic acid was 1.58 mg EMAT 
(38.6% w/w). 
Animals and experimental design 
Sprague-Dawley rats were used from the Faculty of 
Chemistry and Pharmaceutical Sciences animal 
breeding facilities in the Universidad de Chile. The 
experimental protocol was approved by the Bioethics 
Committee of the Faculty of Chemistry and 
Pharmaceutical Sciences. To evaluate the 
pharmacological effect of EMATst on the estrous 
cycle of rats, we used fourteen 3-months-old virgin 
females, with an average weight of 280 g, which 
were maintained under controlled light and 
temperature. The animals were divided into three 
groups: control and experimental groups I and II. 
To experimental group I, we administered a dose of 
EMATst that was the mole-equivalent to dose of 
estradiol valerate (EV) (1x) that produces 
important changes in estrous cycle (Sotomayor-
Zarate et al., 2008). To group II, a dosage 10 times 
greater (10x) was administered. For the in vitro 
pharmacological assay, rat uterus cytosol was 
obtained from five female rats that were 
ovariectomized ten days before being sacrificed 
according to established procedures (National 
Toxicology Program, 2002). The uterus of each female 
was extracted and treated with a standard methodology 
(National Toxicology Program, 2002). The cytosol 
fractions obtained (11 mL) were stored in 1-mL 
fractions at -70º C. 
 
Experimental procedure 
In vivo pharmacological analysis  
EMATst was administered subcutaneously with a 
hypodermic syringe on days 0, 2 and 7 of the 
experimental procedure. All rats were killed after 14 
days from the last dose. Group I received a dosage of 
0.5 mg/300 g/50 µL ethanol (1x) of the extract; group 
II received a dosage of 5.1 mg/300 g/50 µL ethanol 
(10x). The estrous cycle was monitored daily 
beginning 5 days before the EMATst administration 
(day 0) using vaginal smear samples. Diestrus was 
characterized by the presence of leukocytes under 
microscopic observation and a thin non-vascularized 
uterus, whereas proestrus (P) (day before ovulation) 
was characterized by a high density of epithelial cells 
under microscopic observation; this was associated 
with a ballooned and highly vascularized uterus. 
During estrus (E) (day after ovulation), microscopic 
observation revealed a dense accumulation of 
squamous cells and a uterus that had rapidly decreased 
in size but maintained its vascularization. Estrual 
cycling activity was observed over 14 days. 
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 Animals were killed by decapitation, 
collecting trunk blood for serum, and the ovaries, 
adrenal gland and celiac ganglion were removed and 
immediately frozen at -80 ºC for later analysis. Each 
uterus was extracted, observed and weighed. 
 
In vitro pharmacological assay  
We used a methodology to determine the competitive 
binding to the ER in vitro using the cytosol fraction of 
rat uterus and radiolabeled 17 β- estradiol (3H-E2) 
(National Toxicology Program, 2002). We determined 
the 50% inhibition of 
3
H-E2 binding to the ER (IC50) 
and the binding percentage of each competitor. 
 Stock solutions of 17 β- estradiol, EMATst 
and verbascoside were prepared by diluting the 
substances in ethanol. A final volume of 500 µL was 
prepared of each serial dilution using a maximum of 
0.25 µL ethanol. The ER assay was performed in 
round-bottomed 1.7-mL Eppendorf tubes prepared 
in an ice bath with 50 µL uterine cytosol (50 - 100 µg 
protein per assay) and 10 µL 
3
H-E2 to achieve a 
concentration of 0.5 – 1.0 nM, plus non-radioactive 
17β-estradiol or EMATst or verbascoside to compete 
for the binding in a final volume of 500 µL. Tubes 
were incubated at 4 ºC for 18-20 hours with rotation. 
To separate bound from total, 
3
H-E2 tubes were mixed 
with 250 µL of hydroxyapatite solution prepared 
according to the National Toxicology Program (2002). 
After washing 
3
H-E2 three times, the substances was 
eluted with 100% ethanol and measured for 
radioactivity.  
 
Data analysis 
The results were expressed as the average ± SEM, and 
their significance was determined by analysis of 
variance (ANOVA), followed by a multiple 
comparison Turkey test using GraphPad Prism 
Version 5.0. Statistically significant differences were 
established using p  0.05. The same software was 
also used to prepare the graphs. The IC50 was 
estimated using the data of the E2 standard and of each 
sample analyzed by graphing the percentage of bound 
3
H-E2 vs the log molar concentration of the 
competitor.  
 
RESULTS 
The evaluation of the pharmacological effect of 
EMATst on the estrous cycle of rats 
The weight of the animals (300 g) did not change 
significantly in any of the three groups during the 
course of the experiment. In the control group, the 
observed characteristics of the uterus generally 
coincided with the vaginal smears. In the two 
experimental groups, however, there were differences 
in the predicted stage between the gross morphology 
of the uterus and the vaginal smear. In the group of 
animals treated with the highest dose of EMATst, a 
diestrus phase of the cycle was commonly observed in 
the vaginal lavage observation, but this was contrasted 
with a clear morphological aspect of proestrus in the 
uterus of the animals.  
 Regarding estrous cycling activity (Figure 1), 
the control group exhibited a normal 4-day estrous 
cycle, in which P and E lasted one day each and in 
which D lasted two days. Group I exhibited acyclic 
estrous cycling activity characterized by alterations in 
the sequence of the cycle. This difference was clearly 
demonstrated when a 10x dose of EMATst was used 
(Figure 1). For example, after administration of 
EMATst 10x, many rats stopped cycling for the 
duration of the experiment. 
 The number of days that each animal was in 
the different stages of the estrous cycle is shown in 
Figure 2. Cycles were altered in group I compared 
with the control group because the percentage of E 
was greater in group I, whereas P was less than in the 
control group. A greater alteration was observed in 
group II because the percentage of D increased 
compared with the control group, whereas the 
percentage of P decreased considerably (p < 0.001).  
 Figure 3 compares the frequency of ovulation, 
measured as the number of times one P day was 
followed by one E day, which on physiological 
grounds is considered to be the number of ovulations. 
Group 1 exhibited a slight decrease in ovulatory 
capacity compared with the control group, whereas the 
ovulatory capacity in group II decreased considerably 
(p < 0.001)**, which suggests an anti-estrogenic 
effect.
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Figure 1 
 
The Eeffect of EMATst on the estrous cycle of Sprague Dawley rats treated with EMATst: groups I (0.5 
mg/300 g/50 µL) and II (5.1 mg/300 g/50 µL) compared withto the control group with a normal sequence of 
proestrus (P), estrus (E) and diestrus (D). A representative examplebehavior of an individual rat’s behavior 
is shown, and the experimental groups are compared withto the control group.  The Xx- axis indicates the 
day of the assay; the y- axis indicates the estrous cycle of each rat. R  indicates the number of rats. The 
behavior is acyclic in group I, whereasile group II exhibitsshows greater activity. Both experimental groups 
are compared withto the control group. 
 
  
Figure 2 
 
The Ccomparison of the percentage ofs between days spent in the different stages of the estrous cycle inof 
rats treated with EMATst. Group I (0.5 mg/300 g/50 µL) and group II (5.1 mg/300 g/50 µL) are compared 
withto the control group. The bars represent the average percentage for each cycle stage. The Rresults 
correspond to 5 animals in each group and are expressed as the mean ± SEM. *= p < 0.0 5, vs. control.  ** = 
p < 0.001 vs. control. 
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Figure 3 
 
 
The percentage of ovulations of rats treated with 
EMATst: groups I (5.1 mg/300 g/50 µL) and II (5.1 
mg/300 g/50 µL) are, compared withto the control 
group. To calculate theis percentage of ovulation, 
the number of times that a proestrus day was 
followed by an estrus day was considered. The bars 
represent the average percentage. The R results 
correspond to 5 animals in each group and are 
expressed as the mean ± SEM 
** = p < 0.001 vs control. 
 
In vitro pharmacological assay 
Concentration of 17β-estradiol between 10-11 and 
10
-7
 M competed with 
3
H-E2 bound to the receptor 
fraction in a dose-dependent manner, but the same 
doses of EMATst did not.. Higher concentrations of 
verbascoside and EMATst (10
-3
 to 10
-4 
M) in a range 
1000 times greater were able to compete with 17β-
estradiol. After calculating the percentage of binding 
to the receptor, expressed in pmol bound estradiol/mg 
protein (which represents the quantity of E2 bound to 
the receptor that has not been displaced by the 
competitor), we found that both compounds exhibited 
a displacement of 
3
H-E2 (Figure 4). For verbascoside 
and EMATst, the phenomenon was produced at 
concentrations 1000 times greater than those used for 
cold 17β-estradiol. There was also a maximum 
concentration of verbascoside and EMATst at which 
the 
3
H-E2 displacements was produced. Interestingly, 
at higher concentrations, the phenomenon was 
reversed. 
 The values of percent binding in Figure 4 were 
used to estimate the IC50 value of displacement for 
each competitor in each of the experiments performed. 
The graph of the values of IC50 for each competitor 
with respect to the concentration indicates a significant 
increase in the IC50 value both for verbascoside and 
EMATst compared with cold estradiol. Therefore, 
there was displacement of radiolabeled estradiol and 
thus binding of EMATst and verbascoside to the 
estrogen receptor, but this activity was in 
concentrations much greater than that for 17β 
estradiol. 
 
DISCUSSION 
We found evidence that the exposure of adult rats to 
an EMATst of B. globosa leaves disrupts estrous 
cycling activity, most likely in a dose-dependent 
manner and through its binding to the estrogen 
receptor. Although the lower dose of the EMATst used 
was equimolar to that of 17β-estradiol (with a 
concentration of verbascoside of 10
-6 
M), it was not 
able to compete with 17β estradiol in our binding 
study but was able to slightly modify the estrous 
cycling activity of the rats after chronic exposure for 
14 days. Low-dose extract exposure produced an 
increase in the number of estrus cycles observed in the 
rats, suggesting that, at this dose, the extract could acts 
as an endogenous estrogen to accelerate the transition 
between proestrus and estrus. This effect was clearly 
observed at the level of vaginal cytology, as the 
histological appearance changed from epithelial to 
cornified cells. The fact that a 10-fold increase in the 
dose of EMATst (with a concentration in verbascoside 
of 10
-5
 M) produced a clear change in estrous cycling 
activity and in the ovulatory performance gives further 
support to the possibility of a direct effect of the 
extract as a plant-derived estrogen. Significant 
evidence suggests that high doses of estradiol 
produced anovulation in rats and that chronic exposure 
acts at the ovary level as well as in the reproductive 
hypothalamus to block GnRH-induced gonadotropin 
surge (Barría et al., 1993; Weiland et al., 1997; 
Herbison, 1998; Schuiling et al., 1999; Tsai and 
Legan, 2002; Petersen et al., 2003; Kasturi et al., 
2009). If this is the case, we can understand why 
chronic treatment with a 10x dose of the EMATst not 
only affected the estrous cycling activity by increasing 
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the length of time in which rats stayed in diestrus, 
thereby blocking the preovulatory surge of 
gonadotropins, but also why this effect was sufficient 
to block the ovulatory performance of the rat. 
Estradiol could act locally at the ovary and also 
centrally at the hypothalamus. We could likely observe 
both effects by chronic exposure to EMATst. The 
consequences of the disruption of ovulation by chronic 
exposure to an estrogen-disrupting chemical seems 
similar to the one we have previously observed after 
two months of exposure to a single estradiol dose in 
adults rats. The rats developed an acyclic condition, an 
increased sympathetic nerve activity and polycystic 
ovary morphology (Sotomayor-Zarate et al., 2008). 
Likely, we would have observed a similar effect with 
EMATst, a possibility currently under study. The 
results obtained with the two doses suggest a dose-
dependent estrogenic effect. 
  
Figure 4 
 
 
Competition analysis for the E2 cytosolic receptor: The displacement of 3H-E2 by 17β-estradiol, 
verbascoside and EMATst is presentedshown on the left. The values of IC50 are shown on the right. The 
Rresults correspond to 6 animals in each group and are expressed as the mean ± SEM. *** = p < 0.05 vs. 
control. 
 
The possibility of an estrogenic effect from EMATst 
was strongly supported with the binding experiments. 
Rat uterus cytosol has been amply used to study 
binding to estradiol receptors (Baker et al., 1999; Blair 
et al., 2000; Fang et al., 2001). Rat uterus expresses 
principally the alpha subtype of the estrogen receptor, 
and this receptor is up-regulated by estradiol (Wang et 
al., 1999). The fact that EMATst competed for ER 
suggests that it acts through the alpha-estradiol 
receptor. This is a very interesting possibility because 
it could explain why the lower dose of EMATst 
increased the number of days in which cornified cells 
appeared in the vaginal lavages, indicating the local 
effect of EMATst in the vagina through alpha 
receptors, the predominant receptor in this tissue 
(Wang et al., 2000). The increased dose exhibited a 
more pronounced effect in the cycling activity and at 
the reproductive hypothalamus, as was clearly 
observed in the present study. Notably, the pivotal 
behavior of the highest dose of EMATst and 
verbascoside in the binding to the cytosolic fraction of 
rat uterus was important. The fact that higher doses not 
only failed to displace the estradiol but also increased 
the binding to the receptor suggests the up-regulation 
of the alpha estrogen receptors, as has been previously 
found in ovariectomized rats (which have low levels of 
estradiol) treated with estradiol (Nephew et al., 2000; 
Wanda et al., 2007).  
 As we previously demonstrated, EMATs 
exhibit anti-inflammatory and analgesic effects 
(Backhouse et al., 2008a; Backhouse et al., 2008b). 
These data are well correlated with the results obtained 
in this work and those obtained by Zamorano et al. 
(1994), who demonstrated that vascular reactivity and 
vascular prostanoids synthesis are influenced by the 
hormonal changes occurring during the estrous cycle 
of normal female rats and could thus be involved in 
Parada et al. Estrous cycle disruptor effect of Buddleja globosa leaves 
 
 
Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas/196 
 
the effect on estrous cycling activity found in the 
present work. 
 One study correlated the availability of 
verbascoside in plasma after oral administration to 
laboratory rats (Funes et al., 2009). This study 
concluded that verbascoside is absorbed rapidly 
through the gastrointestinal tract, reaching a maximum 
concentration in the first 20 minutes. Although the 
availability of verbascoside by oral administration is 
quite low, it is probable that other metabolites present 
in the extract, such as flavones and other metabolites 
derived from the intestinal biodegradation of 
verbascoside, caffeic acid and other undetermined 
compounds may contribute to the in vivo biological 
activity. The concentration of bioavailable 
verbascoside is in the micromolar range, which allows 
us to suggest that the dosage administered to 
laboratory rats subcutaneously in the study of the 
alteration of the estrous cycle is equivalent to the 
concentrations used in the binding assay. 
 
CONCLUSIONS 
The result of the pharmacological assay on the estrous 
cycle of the laboratory rats may be attributed to an 
antiestrogenic effect of ematst at the highest dose 
evaluated.  
 The results of the binding assay to the 
estrogenic receptor of ematst and verbascoside 
strongly suggests that both compounds bind to the 
estrogenic receptor in concentrations 1000 greater than 
that of 17β-estradiol. 
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